Literature DB >> 10802412

Extrusion-spheronization of pH-sensitive polymeric matrix pellets for possible colonic drug delivery.

K Krogars1, J Heinämäki, J Vesalahti, M Marvola, O Antikainen, J Yliruusi.   

Abstract

The aim of this study was to investigate extrusion-spheronization pelletization for preparing pH-sensitive matrix pellets for colon-specific drug delivery. The effects of three independent variables (amounts of Eudragit S, citric acid and spheronizing time) on pellet size, shape (roundness and aspect ratio), and drug release were studied with central composite design. The pellets contained ibuprofen as a model drug, citric acid as a pH-adjusting agent, Eudragit S as a pH-sensitive binder and microcrystalline cellulose (MCC). The pellets were prepared with Nica extrusion-spheronizing equipment and subsequently enteric-coated using an air-suspension technique. Eudragit S as a pH-sensitive matrix former in pellets increased the pellet size and influenced pellet roundness. In small amounts Eudragit S increased pellet roundness but in larger amounts pellet roundness was reduced. Citric acid promoted the pelletization process resulting in a narrower area distribution. The pH-sensitive matrix pellet failed to delay the drug release. The combination of citric acid and enteric coating, however, delayed the drug release for 15 min in a pH 7.4 phosphate buffer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10802412     DOI: 10.1016/s0378-5173(00)00382-3

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Optimization of hot melt extrusion parameters for sphericity and hardness of polymeric face-cut pellets.

Authors:  Abdullah S Alshetaili; Bjad K Almutairy; Saad M Alshahrani; Eman A Ashour; Roshan V Tiwari; Sultan M Alshehri; Xin Feng; Bader B Alsulays; Soumyajit Majumdar; Nigel Langley; Karl Kolter; Andreas Gryczke; Scott T Martin; Michael A Repka
Journal:  Drug Dev Ind Pharm       Date:  2016-05-04       Impact factor: 3.225

2.  Process optimization, characterization and pharmacokinetic evaluation in rats of ursodeoxycholic acid-phospholipid complex.

Authors:  Peng-Fei Yue; Wen-Jin Zhang; Hai-Long Yuan; Ming Yang; Wei-Feng Zhu; Pei-Lie Cai; Xiao-He Xiao
Journal:  AAPS PharmSciTech       Date:  2008-02-07       Impact factor: 3.246

3.  Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid.

Authors:  Gang Cheng; Feng An; Mei-Juan Zou; Jin Sun; Xiu-Hua Hao; Yun-Xia He
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

4.  Development of a Solid Dispersion System for Improving the Oral Bioavailability of Resveratrol in Rats.

Authors:  Chih-Wei Chang; Cheng-Yu Wong; Yu-Tse Wu; Mei-Chich Hsu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

5.  Formulation and in vitro and in vivo evaluation of film-coated montelukast sodium tablets using Opadry® yellow 20A82938 on an industrial scale.

Authors:  Abdel Naser Zaid; Salam Natour; Aiman Qaddomi; Abeer Abu Ghoush
Journal:  Drug Des Devel Ther       Date:  2013-02-07       Impact factor: 4.162

6.  Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite design.

Authors:  Gurinder Singh; Roopa S Pai; V Kusum Devi
Journal:  J Adv Pharm Technol Res       Date:  2012-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.